1. Home
  2. Labeler Index
  3. Seton Pharmaceuticals
  4. 13925-523
  5. NDC Package Code: 13925-523-01 Azacitidine

NDC Package 13925-523-01 Azacitidine

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory .

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
13925-523-01
Package Description:
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON
Product Code:
13925-523
Proprietary Name:
Azacitidine
Usage Information:
This medication is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells. People with MDS usually have problems such as infections, anemia, and easy bleeding/bruising. Azacitidine is believed to work by helping your bone marrow grow normal blood cells so you will need fewer blood transfusions. Azacitidine also kills abnormal blood cells that have grown too fast and do not work properly.
11-Digit NDC Billing Format:
13925052301
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
Labeler Name:
Seton Pharmaceuticals
Sample Package:
No
FDA Application Number:
ANDA207518
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
05-17-2017
End Marketing Date:
02-13-2018
Listing Expiration Date:
02-13-2018
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 13925-523-01?

The NDC Packaged Code 13925-523-01 is assigned to a package of 1 injection, powder, lyophilized, for solution in 1 carton of Azacitidine, labeled by Seton Pharmaceuticals. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

Is NDC 13925-523 included in the NDC Directory?

The product was first marketed by Seton Pharmaceuticals on May 17, 2017 and its listing in the NDC Directory is set to expire on February 13, 2018 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 13925-523-01?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

What is the 11-digit format for NDC 13925-523-01?

The 11-digit format is 13925052301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-213925-523-015-4-213925-0523-01